Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease

Experimental Biology and Medicine

Volumn 239, Issue 11, 2014, Pages 1524-1530

  Cantorna, Margherita T ^a   McDaniel, Kaitlin ^a   Bora, Stephanie ^a   Chen, Jing ^a   James, Jamaal ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

inflammatory bowel disease; microbiota; Vitamin D

Indexed keywords

CLAUDIN 1; GAMMA INTERFERON; INTERLEUKIN 17; OCCLUDIN; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VITAMIN D;

ARTICLE; CROHN DISEASE; ENVIRONMENTAL FACTOR; HELICOBACTER INFECTION; HEREDITY; HOMEOSTASIS AND REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; INTESTINE FLORA; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS; ANIMAL; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ANIMALS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; VITAMIN D;

EID: 84910093083     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214523890     Document Type: Article

References (73)

1. DeLuca HF. Vitamin D. Nutr Today 1993;28:6–11.
2. Clemens TL,Adams JS,Nolan JM,Holick MF.Measurement of circulating vitamin D in man.Clin Chim Acta. 1982;121:301-8
3. Xavier RJ,Podolsky DK.Unravelling the pathogenesis of inflammatory bowel disease.Nature. 2007;448:427-34
4. Wu F,Dassopoulos T,Cope L,Maitra A,Brant SR,Harris ML,Bayless TM,Parmigiani G,Chakravarti S.Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.Inflamm Bowel Dis. 2007;13:807-21
5. Satsangi J,Jewell DP,Bell JI.The genetics of inflammatory bowel disease.Gut. 1997;40:572-4
6. Cho JH.The genetics and immunopathogenesis of inflammatory bowel disease.Nat Rev Immunol. 2008;8:458-66
7. Verma R,Ahuja V,Paul J.Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population.BMC Med Genet. 2009;10:82-82
8. Naser SA,Arce M,Khaja A,Fernandez M,Naser N,Elwasila S,Thanigachalam S.Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.World J Gastroenterol. 2012;18:412-24
9. Moran CJ,Walters TD,Guo CH,Kugathasan S,Klein C,Turner D,Wolters VM,Bandsma RH,Mouzaki M,Zachos M,Langer JC,Cutz E,Benseler SM,Roifman CM,Silverberg MS,Griffiths AM,Snapper SB,Muise AM.IL-10R polymorphisms are associated with very-early-onset ulcerative colitis.Inflamm Bowel Dis. 2013;19:115-23
10. Xue LN,Xu KQ,Zhang W,Wang Q,Wu J,Wang XY.Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.Inflamm Bowel Dis. 2013;19:54-60
11. Molodecky NA,Kaplan GG.Environmental risk factors for inflammatory bowel disease.Gastroenterol Hepatol. 2010;6:339-46
12. Schultz M,Butt AG.Is the north to south gradient in inflammatory bowel disease a global phenomenon?.Expert Rev Gastroenterol Hepatol. 2012;6:445-7
13. Cantorna MT,Mahon BD.Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.Exp Biol Med (Maywood). 2004;229:1136-42
14. Jussila A,Virta LJ,Salomaa V,Maki J,Jula A,Farkkila MA.High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference.J Crohns Colitis. 2013;7:e256-62
15. Khalili H,Huang ES,Ananthakrishnan AN,Higuchi L,Richter JM,Fuchs CS,Chan AT.Geographical variation and incidence of inflammatory bowel disease among US women.Gut. 2012;61:1686-92
16. Sonnenberg A,McCarty DJ,Jacobsen SJ.Geographic variation of inflammatory bowel disease within the United States.Gastroenterology. 1991;100:143-9
17. Nerich V,Jantchou P,Boutron-Ruault MC,Monnet E,Weill A,Vanbockstael V,Auleley GR,Balaire C,Dubost P,Rican S,Allemand H,Carbonnel F.Low exposure to sunlight is a risk factor for Crohn's disease.Aliment Pharmacol Ther. 2011;33:940-5
18. Backhed F,Ley RE,Sonnenburg JL,Peterson DA,Gordon JI.Host-bacterial mutualism in the human intestine.Science. 2005;307:1915-20
19. Xu J,Gordon JI.Inaugural article: honor thy symbionts.Proc Natl Acad Sci U S A. 2003;100:10452-9
20. Hooper LV,Midtvedt T,Gordon JI.How host-microbial interactions shape the nutrient environment of the mammalian intestine.Annu Rev Nutr. 2002;22:283-307
21. Frank DN,St Amand AL,Feldman RA,Boedeker EC,Harpaz N,Pace NR.Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.Proc Natl Acad Sci U S A. 2007;104:13780-5
22. Guarner F.What is the role of the enteric commensal flora in IBD?.Inflamm Bowel Dis. 2008;14:S83-4
23. Sartor RB.Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.Gastroenterology. 2004;126:1620-33
24. Luther J,Dave M,Higgins PD,Kao JY.Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.Inflamm Bowel Dis. 2010;16:1077-84
25. Hviid A,Svanstrom H,Frisch M.Antibiotic use and inflammatory bowel diseases in childhood.Gut. 2011;60:49-54
26. Kronman MP,Zaoutis TE,Haynes K,Feng R,Coffin SE.Antibiotic exposure and IBD development among children: a population-based cohort study.Pediatrics. 2012;130:e794-803
27. Kitajima S,Morimoto M,Sagara E,Shimizu C,Ikeda Y.Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice.Exp Anim. 2001;50:387-95
28. Sellon RK,Tonkonogy S,Schultz M,Dieleman LA,Grenther W,Balish E,Rennick DM,Sartor RB.Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.Infect Immun. 1998;66:5224-31
29. Kamada N,Kim YG,Sham HP,Vallance BA,Puente JL,Martens EC,Nunez G.Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.Science. 2012;336:1325-9
30. Blanck S,Aberra F.Vitamin d deficiency is associated with ulcerative colitis disease activity.Dig Dis Sci. 2013;58:1698-702
31. Ananthakrishnan AN,Khalili H,Higuchi LM,Bao Y,Korzenik JR,Giovannucci EL,Richter JM,Fuchs CS,Chan AT.Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.Gastroenterology. 2012;142:482-9
32. Mouli VP,Ananthakrishnan AN.Review article: vitamin D and inflammatory bowel diseases.Aliment Pharmacol Ther. 2014;39:125-36
33. Stenson WF,Cort D,Rodgers J,Burakoff R,DeSchryver-Kecskemeti K,Gramlich TL,Beeken W.Dietary supplementation with fish oil in ulcerative colitis.Ann Intern Med. 1992;116:609-14
34. Jorgensen SP,Agnholt J,Glerup H,Lyhne S,Villadsen GE,Hvas CL,Bartels LE,Kelsen J,Christensen LA,Dahlerup JF.Clinical trial: vitamin D3 treatment in Crohn's disease – a randomized double-blind placebo-controlled study.Aliment Pharmacol Ther. 2010;32:377-83
35. Yang L,Weaver V,Smith JP,Bingaman S,Hartman TJ,Cantorna MT.Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients.Clin Transl Gastroenterol. 2013;4:e33-e33
36. Zator ZA, Cantu SM, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Pretreatment 25-Hydroxyvitamin D levels and durability of anti-tumor necrosis factor-alpha therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. Epub ahead of print; 2013.
37. Cantorna MT.Vitamin D, multiple sclerosis and inflammatory bowel disease.Arch Biochem Biophys. 2012;523:103-6
38. Froicu M,Cantorna MT.Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.BMC Immunol. 2007;8:5-5
39. Froicu M,Weaver V,Wynn TA,McDowell MA,Welsh JE,Cantorna MT.A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases.Mol Endocrinol. 2003;17:2386-92
40. Cantorna MT,Munsick C,Bemiss C,Mahon BD.1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.J Nutr. 2000;130:2648-52
41. Daniel C,Sartory NA,Zahn N,Radeke HH,Stein JM.Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.J Pharmacol Exp Ther. 2008;324:23-33
42. Zbar AP,Simopoulos C,Karayiannakis AJ.Cadherins: an integral role in inflammatory bowel disease and mucosal restitution.J Gastroenterol. 2004;39:413-21
43. Marchiando AM,Graham WV,Turner JR.Epithelial barriers in homeostasis and disease.Annu Rev Pathol. 2010;5:119-44
44. Madsen KL,Malfair D,Gray D,Doyle JS,Jewell LD,Fedorak RN.Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora.Inflamm Bowel Dis. 1999;5:262-70
45. Su L,Shen L,Clayburgh DR,Nalle SC,Sullivan EA,Meddings JB,Abraham C,Turner JR.Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.Gastroenterology. 2009;136:551-63
46. Mullin JM,Laughlin KV,Marano CW,Russo LM,Soler AP.Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability.Am J Physiol. 1992;263:F915-24
47. Ooi JH,Li Y,Rogers CJ,Cantorna MT.Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis.J Nutr. 2013;143:1679-86
48. Kong J,Zhang Z,Musch MW,Ning G,Sun J,Hart J,Bissonnette M,Li YC.Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.Am J Physiol Gastrointest Liver Physiol. 2008;294:G208-16
49. Palmer HG,Gonzalez-Sancho JM,Espada J,Berciano MT,Puig I,Baulida J,Quintanilla M,Cano A,de Herreros AG,Lafarga M,Munoz A.Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.J Cell Biol. 2001;154:369-87
50. Yen D,Cheung J,Scheerens H,Poulet F,McClanahan T,McKenzie B,Kleinschek MA,Owyang A,Mattson J,Blumenschein W,Murphy E,Sathe M,Cua DJ,Kastelein RA,Rennick D.IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.J Clin Invest. 2006;116:1310-6
51. Brunkow ME,Jeffery EW,Hjerrild KA,Paeper B,Clark LB,Yasayko SA,Wilkinson JE,Galas D,Ziegler SF,Ramsdell F.Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.Nat Genet. 2001;27:68-73
52. Ochs HD,Gambineri E,Torgerson TR.IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.Immunol Res. 2007;38:112-21
53. Vignali DA,Collison LW,Workman CJ.How regulatory T cells work.Nat Rev Immunol. 2008;8:523-32
54. Cheroutre H,Lambolez F.Doubting the TCR coreceptor function of CD8alphaalpha.Immunity. 2008;28:149-59
55. Das G,Augustine MM,Das J,Bottomly K,Ray P,Ray A.An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease.Proc Natl Acad Sci U S A. 2003;100:5324-9
56. Bendelac A,Savage PB,Teyton L.The biology of NKT cells.Annu Rev Immunol. 2007;25:297-336
57. Veldman CM,Cantorna MT,DeLuca HF.Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system.Arch Biochem Biophys. 2000;374:334-8
58. Ooi JH,Chen J,Cantorna MT.Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?.Mol Aspects Med. 2012;33:77-82
59. Cantorna MT.Why do T cells express the vitamin D receptor?.Ann N Y Acad Sci. 2011;1217:77-82
60. Bruce D,Yu S,Ooi JH,Cantorna MT.Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling.Int Immunol. 2011;23:519-28
61. Cantorna MT,Yu S,Bruce D.The paradoxical effects of vitamin D on type 1 mediated immunity.Mol Aspects Med. 2008;29:369-75
62. Muller K,Odum N,Bendtzen K.1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro.Immunol Lett. 1993;35:177-82
63. Rigby WF,Noelle RJ,Krause K,Fanger MW.The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.J Immunol. 1985;135:2279-86
64. Yu S,Bruce D,Froicu M,Weaver V,Cantorna MT.Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice.Proc Natl Acad Sci U S A. 2008;105:20834-9
65. Yu S,Cantorna MT.The vitamin D receptor is required for iNKT cell development.Proc Natl Acad Sci U S A. 2008;105:5207-12
66. Yu S,Cantorna MT.Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice.J Immunol. 2011;186:1384-90
67. Bruce D,Cantorna MT.Intrinsic requirement for the vitamin D receptor in the development of CD8alphaalpha-expressing T cells.J Immunol. 2011;186:2819-25
68. Wang TT,Dabbas B,Laperriere D,Bitton AJ,Soualhine H,Tavera-Mendoza LE,Dionne S,Servant MJ,Bitton A,Seidman EG,Mader S,Behr MA,White JH.Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.J Biol Chem. 2010;285:2227-31
69. Homer CR,Richmond AL,Rebert NA,Achkar JP,McDonald C.ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.Gastroenterology. 2010;139:1630-41, 41 e1–2
70. Lagishetty V,Misharin AV,Liu NQ,Lisse TS,Chun RF,Ouyang Y,McLachlan SM,Adams JS,Hewison M.Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis.Endocrinology. 2010;151:2423-32
71. Gombart AF,Borregaard N,Koeffler HP.Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.FASEB J. 2005;19:1067-77
72. Kullberg MC,Ward JM,Gorelick PL,Caspar P,Hieny S,Cheever A,Jankovic D,Sher A.Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.Infect Immun. 1998;66:5157-66
73. Winter SE,Baumler AJ.A breathtaking feat: to compete with the gut microbiota, Salmonella drives its host to provide a respiratory electron acceptor.Gut Microbes. 2011;2:58-60